These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 36269726)

  • 1. Prevalence of anal dysplasia and HPV genotypes in gynecology patients: The ANGY cross-sectional prospective clinical study protocol.
    Pache B; Balaya V; Mathis J; Hübner M; Sahli R; Cavassini M; Sempoux C; Mathevet P; Jacot-Guillarmod M
    PLoS One; 2022; 17(10):e0276438. PubMed ID: 36269726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia.
    Hosseini MS; Khosravi D; Farzaneh F; Ebrahimi A; Arab M; Ashraf Ganjoie T; Jamdar F; Moridi A; Chehrazi M
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3071-3075. PubMed ID: 30485943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anal human papillomavirus (HPV) prevalences and factors associated with abnormal anal cytology in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil.
    Cambou MC; Luz PM; Lake JE; Levi JE; Coutinho JR; de Andrade A; Heinke T; Derrico M; Veloso VG; Friedman RK; Grinsztejn B
    AIDS Patient Care STDS; 2015 Jan; 29(1):4-12. PubMed ID: 25361401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cross-Sectional Study of the Prevalence of Anal Dysplasia among Women with High-Grade Cervical, Vaginal, and Vulvar Dysplasia or Cancer: The PANDA Study.
    Batman S; Messick CA; Milbourne A; Guo M; Munsell MF; Fokom-Domgue J; Salcedo M; Deshmukh A; Dahlstrom KR; Ogburn M; Price A; Fleming ND; Taylor J; Shafer A; Cobb L; Sigel K; Sturgis EM; Chiao EY; Schmeler KM
    Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2185-2191. PubMed ID: 36126275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study).
    Kojic EM; Cu-Uvin S; Conley L; Bush T; Onyekwuluje J; Swan DC; Unger ER; Henry K; Hammer JH; Overton ET; Darragh TM; Palefsky JM; Vellozzi C; Patel P; Brooks JT
    Sex Transm Dis; 2011 Apr; 38(4):253-9. PubMed ID: 20966828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of anogenital HPV infection, related disease and risk factors among HIV-infected men in inner-city Johannesburg, South Africa: baseline findings from a cohort study.
    Chikandiwa A; Chimoyi L; Pisa PT; Chersich MF; Muller EE; Michelow P; Mayaud P; Delany-Moretlwe S
    BMC Public Health; 2017 Jul; 17(Suppl 3):425. PubMed ID: 28832285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anal and Cervical High-Risk Human Papillomavirus Genotyping in Women With and Without Genital Neoplasia.
    Bregar AJ; Cronin B; Luis C; DiSilvestro P; Schechter S; Pisharodi L; Raker C; Clark M; Robison K
    J Low Genit Tract Dis; 2018 Apr; 22(2):115-119. PubMed ID: 29481422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women with Cervical High-Risk Human Papillomavirus: Be Aware of Your Anus! The ANGY Cross-Sectional Clinical Study.
    Jacot-Guillarmod M; Balaya V; Mathis J; Hübner M; Grass F; Cavassini M; Sempoux C; Mathevet P; Pache B
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anal dysplasia screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(4):1-43. PubMed ID: 23074504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the prevalence of human papillomavirus and abnormal anal cytology in women at risk.
    Lopez-Cavanillas B; G Benitez C; Serrano M; Sendagorta E; Hernandez A; Bartha JL
    J Obstet Gynaecol; 2021 Oct; 41(7):1139-1144. PubMed ID: 33459109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence and incidence of HPV-related anal cancer precursor lesions in HIV-positive women in the late HAART era.
    Hidalgo-Tenorio C; de Jesus SE; Esquivias J; Pasquau J
    Enferm Infecc Microbiol Clin (Engl Ed); 2018 Nov; 36(9):555-562. PubMed ID: 29208455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Anal HPV and Anal Dysplasia in HIV-Infected Women From Johannesburg, South Africa.
    Goeieman BJ; Firnhaber CS; Jong E; Michelow P; Kegorilwe P; Swarts A; Williamson AL; Allan B; Smith JS; Wilkin TJ
    J Acquir Immune Defic Syndr; 2017 Jul; 75(3):e59-e64. PubMed ID: 28141783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between the cervical and anal HPV infection in women with cervical intraepithelial neoplasia.
    Sehnal B; Dusek L; Cibula D; Zima T; Halaska M; Driak D; Slama J
    J Clin Virol; 2014 Jan; 59(1):18-23. PubMed ID: 24315797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anal study in immunocompetent women with human papillomavirus related lower genital tract pathology.
    Donaire C; Reillo M; Martínez-Escoriza JC; López-Fernández JA
    Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():15-20. PubMed ID: 28161543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women.
    Hessol NA; Holly EA; Efird JT; Minkoff H; Schowalter K; Darragh TM; Burk RD; Strickler HD; Greenblatt RM; Palefsky JM
    AIDS; 2009 Jan; 23(1):59-70. PubMed ID: 19050387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of high-risk human papillomavirus infections and associated cervical dysplasia in HIV-positive pregnant women in Germany: a prospective cross-sectional two-centre study.
    Metz CK; Skof AS; Sehouli J; Siedentopf JP; Gebert P; Weiss F; Alba Alejandre I; Heinrich-Rohr M; Weizsaecker K; Henrich W; Kaufmann AM; Rohr I
    Arch Gynecol Obstet; 2023 Jul; 308(1):207-218. PubMed ID: 36576558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-specific high-risk human papillomavirus infections and risk factors for cervical dysplasia in women with human immunodeficiency virus in Germany: results from a single-center cross-sectional study.
    Wagner A; Skof AS; Sehouli J; Richter R; Henrich W; von Weizsäcker K; Siedentopf JP; Chekerov R; Kaufmann AM; Rohr I
    Int J Gynecol Cancer; 2022 Jun; 32(6):716-723. PubMed ID: 35354606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus genotypes in human immunodeficiency virus-positive patients with anal pathology in Madrid, Spain.
    García-Espinosa B; Moro-Rodríguez E; Álvarez-Fernández E
    Diagn Pathol; 2013 Dec; 8():204. PubMed ID: 24325764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus genotypes in cervical and other HPV-related anogenital cancer in Rwanda, according to HIV status.
    Mpunga T; Chantal Umulisa M; Tenet V; Rugwizangoga B; Milner DA; Munyanshongore C; Heideman DAM; Bleeker MCG; Tommasino M; Franceschi S; Baussano I; Gheit T; Sayinzoga F; Clifford GM
    Int J Cancer; 2020 Mar; 146(6):1514-1522. PubMed ID: 31173641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.